Monopar Therapeutics Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Monopar Therapeutics Inc. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $3.19M, a 295.66% increase year-over-year.
- Monopar Therapeutics Inc. stock issued during period, value, new issues for the quarter ending 2023-09-30 was $265.62K.
- Monopar Therapeutics Inc. stock issued during period, value, new issues for the quarter ending 2023-06-30 was $660.00K.
- Monopar Therapeutics Inc. stock issued during period, value, new issues for the quarter ending 2023-03-31 was $807.34K.
- Monopar Therapeutics Inc. stock issued during period, value, new issues for fiscal 2024 was $4.55M, a 119.65% increase from fiscal 2023.
- Monopar Therapeutics Inc. stock issued during period, value, new issues for fiscal 2023 was $2.07M, a 2273.51% increase from fiscal 2022.
- Monopar Therapeutics Inc. stock issued during period, value, new issues for fiscal 2022 was $87.32K.
- Monopar Therapeutics Inc. stock issued during period, value, new issues for fiscal 2019 was $8.82M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-12-31 | $4.55M 10-K · filed 2026-03-27 | |
| 2024-03-31 | $3.19M 10-Q · filed 2024-11-08 | |
| 2023-12-31 | $2.07M 10-K · filed 2024-03-28 | |
| 2023-09-30 | $265.62K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $660.00K 10-Q · filed 2024-11-08 | |
| 2023-03-31 | $807.34K 10-Q · filed 2024-11-08 | |
| 2022-12-31 | $87.32K 10-K · filed 2024-03-28 | |
| 2021-03-31 | $10.93M 10-Q · filed 2021-05-13 | |
| 2020-09-30 | $6.70M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $950.69K 10-Q · filed 2020-11-12 | |
| 2020-03-31 | $526.14K 10-Q · filed 2021-05-13 | |
| 2019-12-31 | $8.82M 10-K · filed 2021-03-25 | |
| 2017-12-31 | $4.71M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |